Search research articles
Contact Us
Filters
Showing results (11-20 of 22) with videos related to
Page
of 3
Sort By:
International Journal of Radiation Oncology, Biology, Physics
|
July 13, 2024
Acute Toxicity and Early Prostate Specific Antigen Response After Two-Fraction Stereotactic Radiation Therapy for Localized Prostate Cancer Using Peri-Rectal Spacing-Initial Report of the SABR-Dual Trial
Elisha Fredman, Assaf Moore, Oded Icht, et al.
The Oncologist
|
April 4, 2023
Arterial and Venous Thromboembolism in ALK-Rearrangement-Positive Non-small Cell Lung Cancer: A Population-Based Cohort Study
Oded Icht, Avi Leader, Erez Batat, et al.
Oncology
|
July 11, 2021
The Relationship of Diabetes Mellitus to Efficacy of Immune Checkpoint Inhibitors in Patients with Advanced Non-Small Cell Lung Cancer
Oded Jacobi, Yosef Landman, Daniel Reinhorn, et al.
Journal of the Neurological Sciences
|
June 29, 2021
Bevacizumab for stereotactic radiosurgery-induced radiation necrosis in patients with non-small cell lung cancer treated with immune check-point inhibitors
Assaf Moore, Shlomit Yust-Katz, Oded Icht, et al.
Asia-Pacific Journal of Clinical Oncology
|
August 8, 2020
Lower tumor volume is associated with increased benefit from immune checkpoint inhibitors in patients with advanced non-small-cell lung cancer
Oded Icht, Liran Domachevsky, David Groshar, et al.
International Journal of Radiation Oncology, Biology, Physics
|
November 16, 2025
Assessment of the Effective Dose to Immune Cells as an Independent Predictor of Durvalumab Response in Patients With Non-Small Cell Lung Cancer After Chemoradiotherapy: A Multicenter Study
Itamar Averbuch, Sarit Appel, Philip Blumenfeld, et al.
Thoracic Cancer
|
April 24, 2023
Correlations between pathogenic variants in DNA repair genes and anticancer treatment efficacy in stage IV non-small cell lung cancer: A large real-world cohort and review of the literature
Itamar Averbuch, Roi Tschernichovsky, Oded Icht, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
December 10, 2025
The risk of cardiovascular adverse outcomes in patients with thymoma or thymic carcinoma receiving cancer therapy
Inbar Nardi Agmon, Luna Jia Zhan, Gloria Ho, et al.
Journal of Neuro-Oncology
|
February 7, 2024
Converging survival trends in non-small cell lung cancer patients with and without brain metastasis receiving state-of-the-art treatment
Itamar Averbuch, Roi Tschernichovsky, Shlomit Yust-Katz, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
March 24, 2026
Two-year toxicity and PSA dynamics in the initial cohort of the SABR-Dual trial - two-fraction stereotactic radiotherapy for localized prostate cancer using rectal spacing
Elisha Fredman, Mirona Attrash, Eyal Yosefof, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 22) with videos related to
Sort By:
Page
of 3
International Journal of Radiation Oncology, Biology, Physics
|
July 13, 2024
Acute Toxicity and Early Prostate Specific Antigen Response After Two-Fraction Stereotactic Radiation Therapy for Localized Prostate Cancer Using Peri-Rectal Spacing-Initial Report of the SABR-Dual Trial
Elisha Fredman, Assaf Moore, Oded Icht, et al.
The Oncologist
|
April 4, 2023
Arterial and Venous Thromboembolism in ALK-Rearrangement-Positive Non-small Cell Lung Cancer: A Population-Based Cohort Study
Oded Icht, Avi Leader, Erez Batat, et al.
Oncology
|
July 11, 2021
The Relationship of Diabetes Mellitus to Efficacy of Immune Checkpoint Inhibitors in Patients with Advanced Non-Small Cell Lung Cancer
Oded Jacobi, Yosef Landman, Daniel Reinhorn, et al.
Journal of the Neurological Sciences
|
June 29, 2021
Bevacizumab for stereotactic radiosurgery-induced radiation necrosis in patients with non-small cell lung cancer treated with immune check-point inhibitors
Assaf Moore, Shlomit Yust-Katz, Oded Icht, et al.
Asia-Pacific Journal of Clinical Oncology
|
August 8, 2020
Lower tumor volume is associated with increased benefit from immune checkpoint inhibitors in patients with advanced non-small-cell lung cancer
Oded Icht, Liran Domachevsky, David Groshar, et al.
International Journal of Radiation Oncology, Biology, Physics
|
November 16, 2025
Assessment of the Effective Dose to Immune Cells as an Independent Predictor of Durvalumab Response in Patients With Non-Small Cell Lung Cancer After Chemoradiotherapy: A Multicenter Study
Itamar Averbuch, Sarit Appel, Philip Blumenfeld, et al.
Thoracic Cancer
|
April 24, 2023
Correlations between pathogenic variants in DNA repair genes and anticancer treatment efficacy in stage IV non-small cell lung cancer: A large real-world cohort and review of the literature
Itamar Averbuch, Roi Tschernichovsky, Oded Icht, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
December 10, 2025
The risk of cardiovascular adverse outcomes in patients with thymoma or thymic carcinoma receiving cancer therapy
Inbar Nardi Agmon, Luna Jia Zhan, Gloria Ho, et al.
Journal of Neuro-Oncology
|
February 7, 2024
Converging survival trends in non-small cell lung cancer patients with and without brain metastasis receiving state-of-the-art treatment
Itamar Averbuch, Roi Tschernichovsky, Shlomit Yust-Katz, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
March 24, 2026
Two-year toxicity and PSA dynamics in the initial cohort of the SABR-Dual trial - two-fraction stereotactic radiotherapy for localized prostate cancer using rectal spacing
Elisha Fredman, Mirona Attrash, Eyal Yosefof, et al.
Page
of 3